BioCentury | Dec 16, 2013
Strategy

Out in the cold

...Ranbaxy CVS Corticosteroids (pain/ inflammation) Rayos prednisone delayed release Horizon CVS HMG-CoA reductase inhibitors Altoprev lovastatin XL...
BioCentury | Mar 5, 2012
Clinical News

Altoprev lovastatin XL regulatory update

...inhibitors to treat HIV infection and products for certain bacterial and fungal infections. Product: Altoprev lovastatin XL...
...Mevacor and Zocor simvastatin from Merck; Crestor rosuvastatin from AstraZeneca; Lescol fluvastatin from Novartis; Altoprev lovastatin XL...
BioCentury | Feb 29, 2012
Company News

FDA updates statin labels

...Crestor rosuvastatin from AstraZeneca plc (LSE:AZN; NYSE:AZN); Lescol fluvastatin from Novartis AG (NYSE:NVS; SIX:NOVN); Altoprev lovastatin XL...
BioCentury | Apr 20, 2009
Clinical News

Altoprev lovastatin XL: Post-marketing study data

...Pfizer Inc. (NYSE:PFE), New York, N.Y. Shionogi & Co. Ltd. , Osaka, Japan Product: Altoprev lovastatin XL...
...Lipitor atorvastatin from Pfizer; Zocor simvastatin from Merck & Co.; Pravachol pravastatin from Bristol-Myers; and Altoprev...
BioCentury | Mar 23, 2009
Clinical News

Advicor extended release lovastatin/niacin data

...the study were Advicor, Crestor rosuvastatin from AstraZeneca, Lipitor atorvastatin and Caduet atorvastatin/amlodipine from Pfizer, Altoprev...
...Kenilworth, N.J. Shionogi & Co. Ltd. , Osaka, Japan Product: Advicor extended release lovastatin/niacin; Altoprev lovastatin XL...
BioCentury | Apr 4, 2005
Company News

Andrx, First Horizon Pharmaceutical Co. deal

...its previously announced acquisition of ADRX's Fortamet extended-release metformin to treat Type II diabetes and Altoprev...
BioCentury | Mar 7, 2005
Company News

Andrx, First Horizon deal

...Fortamet posted $4.5 million in sales for the third quarter of 2004, while sales for Altoprev...
...U.S. rights to two ADRX drugs: Fortamet extended-release metformin to treat Type II diabetes and Altoprev...
BioCentury | Mar 3, 2005
Company News

First Horizon acquires two Andrx drugs

...FHRX will acquire U.S. rights to Fortamet extended-release metformin and Altoprev extended-release lovastatin from ADRX for...
...$4.5 million in net sales in the third quarter of 2004. Sales of cholesterol drug Altoprev...
BioCentury | Sep 30, 2002
Clinical News

Altocor lovastatin XL: Phase II data; marketed to prevent coronary heart disease

...of Clinical Pharmacology meeting in San Francisco. Andrx Corp. (ADRX), Fort Lauderdale, Fla. Product: Altocor lovastatin XL...
BioCentury | Feb 4, 2002
Clinical News

Altocor extended-release lovastatin regulatory update

...ADRX received an approvable letter from the FDA for its NDA for Altocor lovastatin XL to treat...
Items per page:
1 - 10 of 20